2,201 followers
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab https://t.co/rd3tZnDauG https://t.co/6g3AsCy6Bj
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab https://t.co/rd3tZnDauG https://t.co/6g3AsCy6Bj
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab #lymphoma #lymsm https://t.co/a0pofsoTHu